Evidence map›Paper›PMID 35150876›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022

Clostridioides difficile colonization among very young children in resource-limited settings.

Stephanie A Brennhofer, Elizabeth T Rogawski McQuade, Jie Liu, Richard L Guerrant, James A Platts-Mills, Cirle A Warren

Open access · hybridAbstract read
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Understanding the influence of the microbiome on childhood infections.Expert review of anti-infective therapy · 2024
    Review
  2. Article
  3. Article
  4. Review
  5. International journal of molecular sciences · 2023
    Article
  6. The Impact of a Positive BiofireDiagnostics (Basel, Switzerland) · 2023
    Article
  7. The Hospital Environment as a Potential Source forInternational journal of environmental research and public health · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Stephanie A BrennhoferDivision of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, VA, USA.
Elizabeth T Rogawski McQuadeDivision of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, VA, USA; Department of Epidemiology, School of Public Health, Emory University, Atlanta, GA, USA.
Jie LiuDivision of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, VA, USA; School of Public Health, Qingdao University, Qingdao, China.
Richard L GuerrantDivision of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, VA, USA.
James A Platts-MillsDivision of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, VA, USA.
Cirle A WarrenDivision of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, VA, USA. Electronic address: ca6t@hscmail.mcc.virginia.edu.
University of Virginia · USQingdao University · CN

Funding

Alanyl-glutamine supplementation of standard treatment for C. difficile infectionR01AI145322 · NIAID · UNIVERSITY OF VIRGINIA · PI WARREN, CIRLE ALCANTARA · 2020 to 2024
$4.0M
6 · The paper itself

Abstract

objectivesTo describe the epidemiology and risk factors for Clostridioides difficile (C. difficile) colonization among young children in eight low-resource settings.

methodsWe tested 41 354 monthly non-diarrhoeal and diarrhoeal stools for C. difficile toxin genes (TcdA and TcdB) using quantitative PCR (qPCR) in 1715 children from birth to age two years in a multisite birth cohort study. We estimated the prevalence, cumulative incidence, and seasonality of C. difficile colonization and investigated the associations of C. difficile detection with risk factors of infection, markers of enteropathy, and growth.

resultsThe prevalence of C. difficile detection was lower in diarrhoeal (2.2%; n = 151/6731) compared to non-diarrhoeal stools (6.1%; n = 2106/34 623). By 24 months of age, the cumulative incidence of C. difficile varied widely by site, with 17.9% (n = 44; Pakistan) to 76.3% (n = 148; Peru) of children having at least one positive stool. Only Bangladesh and Pakistan had seasonal differences in C. difficile detection. Female sex (adjusted risk ratio (aRR): 1.18; 95% CI: 1.02-1.35), cephalosporin use in the past 15 days (aRR: 1.73; 95% CI: 1.39-2.16), and treated water (aRR: 1.24; 95% CI: 1.02-1.50) were risk factors for C. difficile positivity. The presence of C. difficile was significantly associated with elevated faecal myeloperoxidase, neopterin, and α-1-antitrypsin, but no associations were found between C. difficile and child growth at 24 months of age. DISCUSSION: C. difficile colonization among children ages 0-2 years was variable across low-resource settings. Significant elevation of intestinal inflammation and barrier disruption markers associated with C. difficile detection suggests a subclinical impact of colonization.

Indexed as

Bacterial ToxinsClostridioides difficileClostridium InfectionsChildChild, PreschoolClostridioidesCohort StudiesDiarrheaFemaleHumansInfantInfant, NewbornBacterial ToxinsC. difficileChildrenClostridioides difficileDiarrhoeaEnteropathyLow-resource settings

Identifiers

PMID35150876
PMCPMC9240321
OpenAlexW4210962816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.